| 000 | 00990 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516230502.0 | ||
| 264 | 0 | _c20150204 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1756-1833 | ||
| 024 | 7 |
_a10.1136/bmj.g3191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSedgwick, Philip | |
| 245 | 0 | 0 |
_aWhat is a crossover trial? _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cMay 2014 |
||
| 300 |
_ag3191 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCannabinoid Receptor Agonists _xtherapeutic use |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDronabinol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aNeuralgia _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 348 _gp. g3191 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.g3191 _zAvailable from publisher's website |
| 999 |
_c24108539 _d24108539 |
||